Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Clinuvel Pharmaceuticals Ltd

+ Add to Watchlist

CUV:AU

3.4000 AUD 0.1000 3.03%

As of 00:10:53 ET on 02/27/2015.

Snapshot for Clinuvel Pharmaceuticals Ltd (CUV)

Open: 3.3000 Day's Range: 3.3000 - 3.4000 Volume: 1,687
Previous Close: 3.3000 52wk Range: 1.3000 - 5.2000 1-Yr Rtn: +126.67%

Stock Chart for CUV

No chart data available.
  • CUV:AU 3.4000
  • 1D
  • 1M
  • 1Y
3.3000
Interactive CUV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CUV

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.2330
Est. EPS (AUD) (06/2015) -
Est. PEG Ratio -
Market Cap (M AUD) 151.29
Shares Outstanding (M) 44.50
30 Day Average Volume 11,020
Price/Book (mrq) 9.3423
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CUV

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for CUV

Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.

Philippe J WolgenManaging Director/CEODarren M KeamyCFO/Secretary
Dennis J WrightActing Chief Scientific OfcrDavina GunnMgr:Investor Rels & Marketing
More Company Profile & Key Executives for CUV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil